Swift Nets $750K Investment from Michigan Accelerator Fund I
January 17, 2013
Swift Nets $750K Investment from Michigan Accelerator Fund I
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Swift Biosciences Licenses Primer Tech to Vela Diagnostics
December 6, 2012 / PCR Insider - VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News - Swift Biosciences Launches BRAF Mutation Assay; Tacks on $2.4M to Series A Financing Round
February 23, 2012 / PCR Insider - Abbott, GSK Add New Biomarker to Cancer Immunotherapy Companion Dx Agreement
December 1, 2011 / PCR Insider - DermTech Replicates Melanoma Test's Microarray Results on OpenArray Tech, Plans Further Validation
November 17, 2011 / PCR Insider